After achieving primary endpoint by demonstrating non-inferiority in HbA 1C reduction from baseline at week 52, investigative insulin icodec h elped patients achieve significantly more time in target blood glucose range (Time in Range) vs. ...
Results from three clinical studies show ecnoglutide to be safe and well-tolerated, and demonstrate robust therapeutic effects in overweight/obese and type 2 diabetes patients On-going Phase 3 clinical trials in Chinese patients with type ...
Entertainment, Fashion, and Sports Personalities to Join More than 160 Youth Delegates with Type 1 Diabetes at the 2023 JDRF Children's Congress, July 9-11 Delegates and families to advocate for renewal of the Special Diabetes ...
First and only continuous glucose monitoring system to be nationally reimbursed in France for people who use once-daily (basal) insulin 1 Expanded reimbursement facilitates wider access to continuous glucose monitoring (CGM) systems, ...
Those who are eligible and complete the 18-hour course will receive a certificate signifying specialized knowledge and competency in evidence-based lifestyle medicine to support the treatment, remission, and prevention of type 2 diabetes and ...
AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of 0.5 mg and 1 mg in DME patients. AG-73305 showed median improvements in Best Corrected Visual Accuity (BCVA) of 8.5 ...
TORONTO and PHILADELPHIA , May 9, 2023 /PRNewswire/ -- A new research study published in JMIR Diabetes evaluated the real-world effectiveness of the Fitterfly Diabetes CGM digital therapeutic program for the management of glycemic ...
Insulin Price Drop Brings Relief to Consumers and Long-Term Care Industry CHICAGO , April 20, 2023 /PRNewswire-PRWeb/ -- UnitedRx , the Midwest's largest full-service, independent long-term care pharmacy, is proud to announce its ...
The Medicare program has expanded access to continuous glucose monitoring systems like the FreeStyle Libre 2 system and the FreeStyle Libre 14 day system for insulin-using 1 Medicare beneficiaries with diabetes, removing the prior requirement ...
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes PITTSBURGH , April 11, 2023 /PRNewswire/ -- LyGenesis, Inc., a clinical-stage biotechnology company developing allogenic ...
Prediabetes raises the risk of dying before age 75, especially from heart disease , kidney disease, and acute diabetic complications. Participants with the stricter definition of prediabetes had 2.6 times the risk of dying from acute diabetic ...
Medical waste from diabetes care, especially from the infusion sets and reservoirs used with insulin pumps, significantly impacts sustainability due to their reliance on single-use plastics ( ). Medtronic's Innovation in Extended ...
Concerning link between diabetes diagnosed in youth and an increased risk of dementia and related neurodegenerative diseases has been highlighted by a new study by researchers in the Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center at ...
A recent meta-analysis conducted at the University of Eastern Finland reveals that 25% of patients aged 16 and above with insulin -dependent diabetes show signs of eating disorder symptoms. Alongside common symptoms like binge eating and food ...
Type 1 diabetes, known as T1D, is characterized by an autoimmune response where harmful lymphocytes attack autoantigens found in the pancreatic islets, resulting in the loss of insulin-producing beta cells in the pancreas. The ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers